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Abstract
The bi-exponential intravoxel-incoherent-motion (IVIM) model for diffusion-
weighted MRI (DWI) fails to account for differential T2s in the model 
compartments, resulting in overestimation of pseudodiffusion fraction f. An 
extended model, T2-IVIM, allows removal of the confounding echo-time (TE) 
dependence of f, and provides direct compartment T2 estimates. Two consented 
healthy volunteer cohorts (n  =  5, 6) underwent DWI comprising multiple 
TE/b-value combinations (Protocol 1: TE  =  62–102 ms, b  =  0–250 mm−2s, 
30 combinations. Protocol 2: 8 b-values 0–800 mm−2s at TE  =  62 ms, with 
3 additional b-values 0–50 mm−2s at TE  =  80, 100 ms; scanned twice). Data 
from liver ROIs were fitted with IVIM at individual TEs, and with the T2-IVIM 
model using all data. Repeat-measures coefficients of variation were assessed 
for Protocol 2. Conventional IVIM modelling at individual TEs (Protocol 1) 
demonstrated apparent f increasing with longer TE: 22.4  ±  7% (TE  =  62 ms) 
to 30.7  ±  11% (TE  =  102 ms); T2-IVIM model fitting accounted for all data 
variation. Fitting of Protocol 2 data using T2-IVIM yielded reduced f estimates 
(IVIM: 27.9  ±  6%, T2-IVIM: 18.3  ±  7%), as well as T2  =  42.1  ±  7 ms, 
77.6  ±  30 ms for true and pseudodiffusion compartments, respectively. 
A reduced Protocol 2 dataset yielded comparable results in a clinical time frame 
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(11 min). The confounding dependence of IVIM f on TE can be accounted for 
using additional b/TE images and the extended T2-IVIM model.
Keywords: diffusion-weighted magnetic resonance imaging, functional 
magnetic resonance imaging, intravoxel incoherent motion, reproducibility 
of results, IVIM, T2IVIM, perfusion magnetic resonance imaging
(Some figures may appear in colour only in the online journal)
Abbreviations
ADC Apparent diffusion coefficient
CoV Coefficient of variation
DWI Diffusion weighted imaging
EPI Echo-planar imaging
GRAPPA Generalised autocalibrating partially parallel acquisition acceleration
IVIM Intravoxel incoherent motion
MR Magnetic resonance
ROI Region of interest
SNR Signal-to-noise ratio
SPAIR Spectral adiabatic inversion recovery
TE Echo time
TR Repetition time
1. Introduction
Diffusion-weighted imaging (DWI) is an important functional imaging technique in oncology, 
where signal intensity modulated by the (diffusive) motion of water molecules can be used to 
inform on tumour cellularity, tortuosity of extracellular space, and microstructural organisa-
tion. While the apparent diffusion coefficient (ADC), conventionally derived by a two-point 
measurement with application of diffusion-sensitising magnetic field gradients of varying 
strengths (b-values), has shown utility in oncology for disease localisation, diagnosis, stag-
ing and assessing therapy response (Yamada et al 1999, Taouli et al 2009, Rosenkrantz et al 
2010, Lee et al 2011, Pope et al 2012, Song et al 2013), the diffusion decay curve in tissues is 
often observed to deviate from the single exponential behaviour expected by simple Gaussian 
diffusion (Lemke et al 2009, Koh et al 2011, Rosenkrantz et al 2015, Winfield et al 2015, 
Jerome et al 2016). The nature and utility of this non-monoexponential signal decay observed 
in multiple b-value DWI is a source of much discussion (Chandarana et al 2011, Dyvorne 
et al 2013). The two-compartment intra-voxel incoherent motion (IVIM) model proposed by 
Le Bihan et al (1988) is a popular choice for diffusion studies in the body, with the associated 
pseudo-diffusion volume parameter f being a potentially useful biomarker in oncology for 
lesion characterisation or response. In the two-compartment model framework, components 
are commonly taken to represent pseudo-diffusion and true diffusion, which may in turn rep-
resent vascular and tissue compartments, giving signal dependence on b-value according to:
= − +∗S b S T f bD f bD, TE exp TE exp – 1 – exp –0 2( ) ( / )[ ( ) ( ) ( )] (1)
Where f is the pseudo-diffusion volume fraction, D and D* are the true- and pseudo-diffusion 
coefficients, and T2 is the transverse relaxation time, implicitly assumed to be the same in both 
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compartments. Standard DWI protocols are commonly acquired at a single echo time (TE), 
most often the minimum, determined by the time required to include the largest diffusion gra-
dient alongside the spin-refocusing pulse and the imaging readout. The TE and T2 dependency 
is typically absorbed into the signal scaling term S0.
It is known, however, that blood and tissue have distinct and variable T2 values, and failure 
to account for this in the IVIM model leads to the mis-assignment of differential T2 signal 
decay between compartments, and thus incorrect estimation of the relative fractional volumes 
of the two compartments. Specifically, as blood is known to have a longer T2 than tissue, the 
pseudo-diffusion volume fraction f is overestimated as a function of increasing echo time 
(Lemke et al 2010). The early IVIM literature recognises the potential for this assumption to 
interfere with the IVIM modelling of DWI: ‘…the perfusion factor is obtained, depending on 
the difference in T2 between the static and flowing component’ (Le Bihan et al 1988).
Inclusion of distinct transverse relaxation constants, referred to in this work to as T2p and 
T2t for pseudo- and true diffusion compartments respectively, modifies the standard IVIM 
model for echo time dependency (equation (2)):
( )( ) ( ) / ( ) ( ) ( / )= +∗⎡⎣ ⎤⎦S b S f bD T f bD T, TE exp – exp –TE 1 – exp – exp –TEp t0 2 2
 
(2)
where S0 is a scaling term independent of both diffusion and T2 effects, and it is implicitly 
assumed that repetition time (TR) is long enough to ensure no significant modulation of the 
signal from incomplete T1 relaxation. An apparent pseudo-diffusion volume fraction can be 
defined using equation (2) by taking a weighted combination of the terms scaling the b-value 
dependent exponentials, that is:
( ) ( )( ) / / ( ) ( / )= + −⎡⎣ ⎤⎦f f T f T f TTE exp –TE exp –TE 1  – exp –TEp p tapp 2 2 2 1 (3)
This formula gives the pseudo-diffusion volume fraction that would be estimated using equa-
tion (1) for a given set of parameters and echo time. Thus, when T2p  =  T2t we have fapp(TE)  =  f, 
which does not depend on TE, but whenever T2p  ≠  T2t the pseudo-diffusion volume fraction 
estimated using equation (1) will depend on TE to some degree.
While it would be desirable to acquire a full sampling of the b-value/TE space for fitting of 
the extended T2-IVIM model in equation (2) to obtain both diffusion and relaxation param-
eters for each compartment, this is limited in practice by available signal-to-noise ratio (SNR) 
at larger b-TE combinations, and the potential for the acquisition time to become prohibitively 
long for a clinical examination.
The purpose of this prospective volunteer study is to develop and present a clinically feasi-
ble multiple b-TE measurement, enabling estimation of the pseudo-diffusion volume fraction 
in the liver that is not dependent on the echo time. In doing this, we demonstrate that the T2 
relaxation times of both compartments are distinct and can be estimated directly from the data, 
and which are thus available as biomarkers in their own right, in contrast to previous methods 
that take an assumed value for T2 associated with the pseudo-diffusion compartment (Lemke 
et al 2010).
2. Materials and methods
2.1. MRI acquisition
This prospective study was approved by the Institutional Review Board. Eleven volunteers 
were consented (age range 25–61, median 31) and imaged in two groups using two proto col 
variants with different b-values and echo times. Protocol 1 used five volunteers and acquired 
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all combinations of six b-values: 0, 50, 100, 150, 200, 250 mm−2s and five TEs: 62, 72, 82, 
92, 102 ms in order to explore the effect of TE on the signal curve. The ranges of b-values 
and TEs were selected to explore the b-TE space while retaining adequate signal-to-noise 
ratio (SNR); the range of 0–250 mm−2s means the data are not optimised for robust quantita-
tive IVIM analysis, but in the healthy liver are adequate for assessing the pseudo-diffusion 
components of the proposed model (Jerome et al 2013). These data were then used to design 
Protocol 2 with a reduced set of b-value TE combinations added to a conventional multiple 
b-value diffusion protocol. A conventional 8-b-value acquisition (0, 10, 50, 100, 150, 200, 
250, 400, and 800 mm−2s at TE 62 ms) was acquired with additional images taken at 3 b-val-
ues (0, 10, 50 mm−2s) with TE 80 and 100 ms. The overall acquisition time of Protocol 2 
was approximately matched to Protocol 1 by increasing the number of signal averages, and 
Protocol 2 was evaluated on the remaining six volunteers. Volunteers imaged with Protocol 
2 were scanned twice, approximately 1 month apart (median 29 days; range 14–43), in order 
to assess repeatability of the derived parameters. All imaging was performed in free-breath-
ing using a 1.5 T MAGNETOM Avanto clinical MR scanner (Siemens Healthcare, Erlangen, 
Germany), using a prototype echo-planar imaging diffusion sequence that allowed explicit 
control of diffusion delay (δ) and diffusion time (Δ). DWI data were acquired coronally 
(to simplify subsequent image registration) using a 3-scan trace-weighted monopolar diffu-
sion scheme, each scan stored separately, with TR  =  4000 ms (sufficient to avoid T1 weight-
ing), FOV  =  380  ×  380 mm2, 16 contiguous 5 mm slices, matrix  =  128  ×  128 (interpolated 
to 256  ×  256), bandwidth  =  1628 Hz/pixel, spectral adiabatic inversion recovery (SPAIR) 
fat suppression, and generalised autocalibrating partially parallel acquisition acceleration 
(GRAPPA) factor 2. The TEs and b-value combinations, described above and represented 
schematically in figure 1, were acquired with the additional parameters:
Protocol 1: δ  =  17.6 ms, Δ  =  24.0 ms, 6/8 partial Fourier acquisition, and 5 repeated 
acquisitions. Thirty b-TE combinations were acquired in a regular array (b: 0–250 mm−2s, 
TE: 62–102 ms), for a total acquisition time of 36 min for each of n  =  5 volunteers.
Protocol 2: δ  =  16.0 ms, Δ  =  20.2 ms, 7/8 partial Fourier acquisition, and 12 repeated 
acquisitions. A reduced set of 14 b-TE combinations were acquired (see also figure 1) that 
includes an additional small b-value (b  =  10 mm−2s), which more closely matches typical 
clinical multi-b-value DWI protocols, giving a total acquisition time of 25 min for each of 
n  =  6 volunteers.
2.2. Data analysis
All analysis was performed using in-house software developed with MATLAB (The 
Mathworks Inc., Natick, MA USA). For each volunteer scan, a single slice showing the larg-
est cross section area of the liver was chosen for analysis, without excluding large vessels 
or ducts; in repeated datasets, the matching slice was chosen. Images were acquired without 
averaging (Jerome et al 2014), and alignment of every image within each dataset (b and TE) 
was performed using a rigid shift based on the liver-diaphragm boundary, and a region of 
interest (ROI) was drawn covering the whole liver section.
For the exploratory data in Protocol 1, the signal intensity was averaged for all voxels in 
the ROI for each image, and this value was used in the model fitting. The extended T2-IVIM 
model was applied using all images, and in addition, the standard IVIM model was applied 
independently for all images at each TE. For Protocol 2, the T2-IVIM model was applied to all 
data, as well as the standard IVIM model for the conventional IVIM data (8 b-values) acquired 
at the lowest TE value (62 ms). Initial parameter values for IVIM fitting were obtained by a 
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two-step fitting of a mono-exponential function to data points with b  >  150 mm−2s to pro-
vide an estimate of D. This fit is then projected back to b  =  0 mm−2s to provide an estimate 
of f from the excess measured signal at b  =  0 mm−2s value above the projected intercept, 
expressed as a fraction. For the T2-IVIM modelling, the same initialisation strategy can be 
used alongside an estimate of T2t from fitting the multiple-TE data at b  =  50 mm−2s as this is 
sufficient to effectively remove the flow component in the liver (Jerome et al 2013).
For data from Protocol 2, both IVIM and T2-IVIM models were also fitted in a voxel-by-
voxel basis to allow generation of functional parameter maps across the whole liver ROI. 
Lastly, in order to assess the use of the extended T2-IVIM model within a realistic clinical 
DWI examination time, a ‘minimised’ subset of the Protocol 2 data using only the first six 
repeated acquisitions of each b-TE combination, and excluding the scans at b  =  10 mm−2s 
for TE 80 and 100 ms (figure 1), for a total effective acquisition time of 10 min 45 s. The 
repeated measures coefficient of variation (CoV, %) was calculated for each parameter across 
the cohort in Protocol 2, using log-transformed measurement values (Limpert et al 2001). 
Statistical analysis of derived IVIM parameters was performed using analysis of variance 
(ANOVA) for repeated visits across the IVIM and T2-IVIM models.
3. Results
Figure 2 shows a typical example data set using Protocol 1, with the standard IVIM model 
applied at each TE (figure 2(a)); in figure 2(b), the TE-dependence of the pseudo-diffusion 
volume fraction computed using the standard IVIM model is shown (open circles) along with 
a curve showing the apparent pseudo-diffusion volume fraction (equation (3)) as a function 
of TE computed using parameters obtained from the extended T2-IVIM model fit. The limit 
of this curve at TE  =  0 ms gives the TE-independent pseudo-diffusion volume fraction, and 
the figure shows that this is significantly lower than that reported by the standard IVIM model 
at all echo times. Fitting the whole dataset with the extended T2-IVIM equation  yields a 
surface that accounts for all the variation in the data (figure 2(c)), and this also shows the T2 
Figure 1. Schematic of acquisition strategy, showing b-TE value combinations in 
Protocol 1 (blue, 5 signal averages) and 2 (red, 12 signal averages). Circles indicate 
excluded data for the ‘reduced’ subset of Protocol 2 (6 signal averages, making the 
clinically-practical 11 min acquisition).
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attenuation with TE for all b-values. Figure 2(d) shows that there are no systematic features 
in the fit residuals.
Table 1 gives f estimates for each TE from Protocol 1 for each volunteer, and shows that 
the apparent increase in f at higher TE is consistent across the volunteer cohort. Acquiring 
multiple b-value images at a non-zero minimum TE consistently overestimates the pseudo-
diffusion volume fraction, by a variable amount that reaches over 100% in three cases, and 
which may be expected to vary across scanners. The effect is exacerbated at longer TEs, indi-
cating that the overestimation is dependent on the exact acquisition protocol.
Parameters derived from fitting the conventional IVIM and the extended T2-IVIM model 
using Protocol 2 are given in table 2, which reports both the mean and standard deviation for 
the liver ROI across the cohort, for the cases of fitting the ROI mean signal in each image, 
the ROI median value of the voxel-wise fitting, and the ROI mean signal from the ‘minimal’ 
subset of b-TE and signal averages. The median is less sensitive to outliers such as partial 
voluming of different tissues at the ROI edge, and large vascular features within the liver, and 
is commonly reported as a more robust summary statistic than the mean. No parameters were 
found to be significantly different between repeated scans, in either model (p  >  0.20 in all 
Figure 2. Example from volunteer in Protocol 1. Panel (a) shows the measured signals 
and fits using the standard IVIM for each TE separately; (b) shows the estimated f 
values from the standard fits in (a) with 95% standard error bars, and also the variation 
of the apparent pseudo-diffusion volume fraction (equation (3)) obtained using the 
parameter estimates with the extended model. Panel (c) shows the measured signals 
and fitted surface using the extended T2-IVIM model, with (d) showing the fit residuals 
from the T2-IVIM model for all combinations of TE and b-value using the same TE 
colour-coding as panel (a) with the smallest TE on the left of each group.
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cases, ANOVA), or between the minimal or full data sets (p  >  0.70, ANOVA). The values for 
D and D* were not significantly changed between the IVIM and T2-IVIM models (p  =  0.50 
and 0.20 respectively, ANOVA), but were both lower when considering the median voxel 
value when compared to the mean (p  >  0.05, ANOVA); values for D* are reported here as 
output of the fitting process, but owing to the known difficulty of obtaining accurate values 
for D*, interpretation of this parameter is explicitly avoided in this work. Values for f are sig-
nificantly lower for the T2-IVIM model (p  <  0.0001, ANOVA). These results, also shown as 
ladder plots of the IVIM parameters (from fitting mean of ROI) in figure 3, clearly show that 
the effect of modelling for separate T2 consistently and significantly reduces the estimated 
value of f. The values for the compound parameter fD* similarly drop when using the T2-IVIM 
model (p  <  0.001, ANOVA).
A typical example of f maps from the two models, from voxel-by-voxel model fitting, is 
presented in figure 4(a); the smaller f observed in the T2-IVIM fitting is consistent in the liver 
parenchyma and well-visualised as a difference map, and by the histogram of f differences 
Table 1. Apparent perfusion volume fraction f calculated from mean of ROI data from 
Protocol 1 using conventional IVIM model (equation (1)) at each unique TE. There is 
an increasing overestimate of f with longer TEs across the cohort.
TE (ms)
Volunteer
Mean  ±  s.d.1 2 3 4 5
102 0.305 0.227 0.474 0.209 0.322 0.307  ±  0.105
92 0.275 0.224 0.432 0.186 0.308 0.285  ±  0.094
82 0.246 0.222 0.391 0.165 0.295 0.264  ±  0.085
72 0.220 0.220 0.351 0.146 0.282 0.244  ±  0.077
62 0.195 0.217 0.311 0.128 0.269 0.224  ±  0.070
T2-IVIM model 0.090 0.203 0.136 0.057 0.199 0.137  ±  0.065
% error for TE  =  62 117.7 6.9 128.9 126.0 35.1 82.9  ±  57.5
Table 2. Diffusion parameters from (i) mean of ROI signal, (ii) median of voxel- 
by-voxel fitting, and mean of ROI from ‘minimal’ sampling of Procotol 2 data. Results 
are mean  ±  s.d. across the cohort, Bold indicates p  <  0.05 for t-test between IVIM and 
T2-IVIM models.
ROI mean Voxel-wise median Minimal set
IVIM
f 0.279  ±  0.06 0.240  ±  0.06 0.277  ±  0.06
D* (mm2 s−1) 0.153  ±  0.025 0.137  ±  0.025 0.161  ±  0.024
D (10−3 mm2 s−1) 1.07  ±  0.06 1.01  ±  0.06 1.08  ±  0.05
fD* (mm2 s−1) 0.043  ±  0.013 0.033  ±  0.011 0.045  ±  0.012
T2-IVIM
f 0.183  ±  0.07 0.179  ±  0.07 0.181  ±  0.06
D* (mm2 s−1) 0.164  ±  0.019 0.148  ±  0.016 0.161  ±  0.025
D (10−3 mm2 s−1) 1.08  ±  0.06 1.03  ±  0.06 1.08  ±  0.05
fD* (mm2 s−1) 0.030  ±  0.013 0.026  ±  0.011 0.029  ±  0.011
T2p (ms) 77.6  ±  30.2 82.0  ±  44.5 90.9  ±  47.7
T2t (ms) 42.1  ±  6.8 41.5  ±  6.5 42.3  ±  6.4
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(figures 4(b) and (c)). Vascular features are retained in the T2-IVIM f map, showing the abil-
ity of the model to deal with varying tissue composition through the ROI. Voxels where the 
estimate of f is higher in the T2-IVIM model appear to correspond to large vascular features 
within the liver, and at the top boundary of the liver where there may be increased uncertainty 
owing to respiratory motion. The difference map also shows that over smaller ROIs in the liver 
parenchyma, such as may correspond to the size of a lesion, the reduction in f is consistently 
present.
Estimation of the T2 values for the pseudo- and true diffusion compartments derived from 
the T2-IVIM model, given in table 3, show good repeatability for T2t (CoV  <  10%) but less 
so for T2p, with correspondingly high variation (CoV  >  20%) seen for T2p and f. The values 
given for T2t are consistent with literature values (Stanisz et al 2005), although the T2p is lower 
than literature values for blood at 1.5 T. A representative T2t map from the T2-IVIM model is 
shown in figure 4(d), and is largely free of vascular features.
The same parameters derived from the ‘minimal’ subset of data from Protocol 2, limited 
to simulate the constraints of acquisition within a clinical time frame, show results for the 
T2-IVIM fitting that are equivalent to those derived from the full dataset (figure 5). The CoVs 
Figure 3. Ladder plots of f, D*, D, and fD* for individuals (grey, average of repeat 
measures) and mean (black) across the cohort, fitting the mean ROI signal of data using 
Protocol 2.
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Figure 4. (a) Calculated pseudo-diffusion fraction f maps from IVIM (left) and T2-
IVIM (right) models using Protocol 2 data. The difference map (b) and histogram (c) 
show the reduction in f, given by T2-IVIM value minus IVIM value, observed when 
allowing for different T2s in the model compartments. The true-diffusion compartment 
T2 map is shown in (d).
Table 3. Coefficients of variation (%) of parameters derived from conventional IVIM 
and T2-IVIM modelling of data from Protocol 2, for fitting mean of ROI, median of 
voxel-by-voxel, and using the minimally-sampled dataset.
ROI mean Voxel-wise median Minimal set
IVIM
f 4.9 7.0 6.3
D* 6.1 9.6 12.6
D 5.0 4.9 4.5
fD* 7.7 10.7 13.6
T2-IVIM
f 23.4 35.0 30.5
D* 4.3 5.6 14.7
D 4.5 4.5 4.5
fD* 24.4 36.7 37.3
T2p 21.4 25.4 33.8
T2t 6.3 7.0 6.7
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for the minimal dataset also match those from the full set; namely, below 10% for D and T2t, 
but higher from parameters relating to the pseudo-diffusion volume fraction (f, D*, and T2p).
4. Discussion
More complex diffusion models than assumed monoexponential decay have the potential to 
inform on microstructure in tissues where more complex phenomena than Gaussian diffu-
sion are present. In many tissues, a second exponential is included, giving the IVIM model, 
which allows inference of vascular fraction and tissue perfusion properties. Such measures are 
becoming increasingly important in oncology to differentiate tumour type or grade (Yamada 
et al 1999, Chandarana et al 2011), or where the focus of a treatment may be anti-angio-
genic or reducing tumour vascularity (Kim et  al 2016, Yang et  al 2016). In using models 
Figure 5. Correlation of T2-IVIM parameters for fitting the mean ROI signal between 
the full Protocol 2 and the minimal set acquired within a clinical time frame: (a) D 
(×10−3 mm2 s−1), (b) f (%), (c) T2t (ms), and (d) T2p (ms).
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with additional parameters, however, there is the potential for over-fitting, or having strongly 
covariant parameters that do not supply additional information. Conversely, if the model being 
used to fit the data is an insufficient description of the system being studied, unmodelled 
variation in the data will manifest as bias in the parameter estimates, and confound any con-
clusions. In addition, any derived parameter being used as a biomarker, e.g. for diagnosis or 
treatment response, must be understood in terms of its sensitivity, reproducibility across scan-
ners/sites, and stability across repeated measurements.
The parameter f, derived from the IVIM model, is formulated and often reported as the 
perfusion or vascular fraction; while the original discussion of the model identified the com-
pound parameter fD* as related to perfusion (Le Bihan et al 1988), this work also identified 
that failure to allow for distinct T2 values for the two components in the IVIM model results 
in f having a TE dependence. In cases where the two compartments have sufficiently different 
T2 values, the estimation of f will be significantly affected. In practical terms, the minimum 
TE often used for clinical DWI is determined by the diffusion encoding scheme, the gradient 
hardware, and the maximum b-value used; it is thus problematic to draw general conclusions 
regarding f where the data may have been acquired using different TEs. This sequence vari-
ation is common for acquisitions in different centres where different scanners are used, and 
so this issue will be particularly relevant for multicentre clinical trials where rarity of disease 
mandates participation from many sites. A TE-independent f would remove this problem and 
potentially increase the utility and specificity of f (and fD*), especially in the multicentre trial 
setting as relating to perfusion.
In this study we show that a complete formulation of the IVIM model, extended to allow for 
distinct T2 values in the two diffusion compartments, can account for the observed variation 
in f with TE. Extending data acquisition to include multiple TE as well as b-values, combined 
with fitting the T2-IVIM model allows estimation of compartment T2s alongside conventional 
IVIM parameters. We demonstrate that this new T2-IVIM model can be applied in a clinically 
relevant setting, adding only a small number of scans to a conventional multiple-b-value DWI 
protocol. With current interest in optimising b-values for IVIM acquisition (Jambor et al 2014, 
Kaya and Koc 2014, Leporq et al 2015), addition of b-values at distinct TEs is entirely feasible 
for routine clinical studies, and will provide facility for T2-IVIM modelling as well as greater 
data support for estimation of S0, crucial for the IVIM model.
The results of this study, consistent with previous work (Lemke et al 2010), show that with 
a finite and non-zero TE, f in the normal liver is routinely overestimated; with a typical TE of 
62 ms, such overestimation appears variable across subjects, but in several cases is over 100%, 
which indicates that f cannot be straightforwardly interpreted as a perfusion volume fraction. 
If the overestimation is due to a differential T2 in the pseudo-diffusion compartment, then 
oxygenation status of the blood may also play a role in the f value derived, again suggesting 
that f cannot be reliably interpreted as vascular fraction. Certainly, the use of different TEs will 
create variation in observed f, and so the use of the extended T2-IVIM model may thus lead to 
a greater ability to standardise the use of IVIM for clinical trials, particularly in a multi-centre 
setting or where repeated MR scans are performed on different scanners.
Previous work by Lemke et al using a literature value for tissue and blood promises retro-
active compensation for overestimation of f, but this is based on the dual assumptions that the 
literature T2 value is correct, and that the IVIM model itself correctly identifies the pseudo-
diffusion volume fraction as pure blood. The T2-IVIM method avoids these assumptions, and 
directly estimates the separate T2 values; our results in this study consistently show a T2 of 
the pseudo-diffusion compartment in the healthy liver of around 80 ms, which is notably dif-
ferent to the literature value of 290 ms for blood used by Lemke et al, and suggests that the 
use of a literature value, while having the benefit of being applicable to legacy data following 
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acquisition, may give a significant underestimation of f and thus be an imperfect or partial 
solution compared to allowing the T2 value to be estimated from prospectively acquired data. 
This discrepancy in derived pseudodiffusion compartment T2 may highlight the difficulty of 
measuring blood T2 in vivo, or may reflect phenomena such as water exchange unaccounted 
for in the IVIM model. The T2 values found for the liver tissue in this study are consistent with 
literature values (Stanisz et al 2005).
Repeatability estimates found for IVIM parameters in this work are remarkably good, with 
small coefficients of variation (<10%) for f, D*, and D using the standard IVIM model in the 
liver. While D has previously been found to be highly repeatable, the pseudo-diffusion param-
eters are commonly reported to be less stable in tumours (Jerome et al 2016), thus caution is 
required when using these parameters to infer physiological change (Winfield et al 2015). For 
fitting with the extended T2-IVIM model, CoV values for D and D* remain low, and there is 
a correspondingly low CoV for the T2 of the slow diffusion compartment (6.3%). The CoVs 
for f and T2p are larger, at  >20%, and reflect how variations in T2p and f manifest the same 
way in the diffusion decay curve. The small reduction in CoV observed for D* may indicate 
an improved ability of the T2-IVIM model to separate f and D*, and the low CoV of the T2t 
parameter suggests that it may be used as a robust imaging marker in a more specific sense 
than the (more commonly used) apparent T2 (Raza et al 2012, Guimaraes et al 2016).
It is worth noting that in diagnostic applications where the comparison between normal and 
pathological f values is of primary interest, the superior repeatability of the conventional IVIM 
model may be advantageous. However, in applications where longitudinal changes occur, 
where there is comparison between individuals, or in the context of a multi-centre clinical 
trial, the additional information provided by the T2-IVIM may outweigh the increased CoV 
for this model.
Most importantly for this study, the increased CoV observed for f in the T2-IVIM model 
compared to the conventional IVIM model, highlights the strength of the interdependence 
of f and T2p, and indicates that the apparent robustness of f estimates from the conventional 
IVIM model may be superficial. These results indicate that a greater investment of scanning 
time into T2 estimation, from either an extended TE range or greater TE sampling, would help 
to reduce the CoV on T2p and by extension f. The CoV for f from T2-IVIM in this study is 
still lower than that seen for f in many IVIM repeatability studies in tumours (Dyvorne et al 
2014, Winfield et al 2015, Jerome et al 2016), underscoring the difficulty of interpreting these 
parameters in the clinical context. In single-scanner settings where the scanning protocol is 
unchanged, these data show that whilst the conventional IVIM scheme gives lower CoV than 
the T2-IVIM scheme, for this to translate into improved treatment sensitivity it is necessary 
to assume that the treatment does not change the T2 of blood in the pathology. The relative 
simplicity and robustness of the conventional IVIM approach lends itself to diagnostic util-
ity, but the T2-IVIM scheme has the potential to provide data in a more controlled setting to 
further our understanding of a potentially important source of variation affecting f estimates 
in different pathologies. In addition, accounting for known influence of acquisition parameters 
will increase the reliability of cross-scanner comparisons.
Limitations of this study include the lack of an available gold standard to measure the 
actual vascular fraction, since this appeared to be variable across the volunteers, and the lim-
ited range of TE used for T2 estimation due to limitations in available SNR. Furthermore, we 
have not applied this technique to evaluate a range of oncological pathologies, which will be 
pursued in prospective studies. In this study, the effects of diffusion time and gradient profile 
were not explored, which may be expected to have an effect on the estimated f (Thian et al 
2014).
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In conclusion, the standard IVIM model is liable to give inaccurate values for the pseudo-
diffusion volume fraction, often termed the perfusion fraction, owing to the invalid assump-
tion that the two model compartments have similar T2 relaxation. The larger T2 value in the 
pseudo-diffusion volume fraction will lead to a consistent overestimation of f, which will be 
dependent on the intrinsic characteristics of the spins in that compartment, and is not simply 
the perfusion fractional volume. Acceptable CoV for such parameters may give false con-
fidence in their accuracy or utility of such, and is a serious confounding factor for IVIM 
modelling. The addition of two low b-value scans at additional TEs allows estimation of the 
T2 values for each compartment alongside the standard IVIM parameters using the extended 
model, giving a more accurate picture of the pseudo-diffusion volume fraction, as well as 
the limit of useful interpretation, for use in clinical trials and improved standardisation of 
advanced diffusion model parameters.
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